Actelion's orphan drug Opsumit recommended for European approval
This article was originally published in Scrip
Executive Summary
Opsumit, Actelion's orphan drug to treat the life-threatening incurable condition pulmonary arterial hypertension has been recommended for approval by the committee that considers the suitability of drugs for marketing authorization in Europe.